| M |
|
MAGNESIUM IONS BIND TO THE FACTOR X (FX) GLA DOMAIN AND PROMOTE FX ACTIVATION BY FACTOR VIIA BOUND TO SOLUBLE TISSUE FACTOR (TF) BUT ACT INHIBITORY WHEN BOUND TO LIPIDATED TF
|
| Persson E. |
| |
|
MAJOR ABDOMINAL SURGERY IN A PATIENT WITH SEVERE HAEMOPHILIA A AND HIGH INHIBITOR TITRE
|
| Salaj P., Gurlich R., [Scaron]vorcová V., Hrachovinová I., Marková M., Maaloufová J., Válková V., Cetkovský P. |
| |
|
MAJOR BLEEDING IN ACUTE CORONARY SYNDROME PATIENTS IS ASSOCIATED WITH A MAKED PRO-INFLAMMATORY RESPONSE: RESULTS FROM THE ACUITY INFLAMMATORY BIOMARKER SUB-STUDY
|
| Jozic J., Steinhubl S.R., Mehran R., Hooper W., Stone G.W., Dangas G. |
| |
|
MAJOR CHANGES IN THE DIAGNOSTIC WORK-UP OF PULMONARY EMBOLISM BETWEEN 1999 AND 2004
|
| van Stralen K.J., Pomp E.R., Bezemer I.D., Doggen C.J.M., Büller H.R., Rosendaal F.R. |
| |
|
MAJOR OBSTETRIC HAEMORRGHAGE IN LATE TERMINATION OF PREGNANCY
|
| Sekhar M., Narat S., LeDieu R., Luqmani A., Hollamby S., Alobaidi M., Hughes G. |
| |
|
MAJOR OBSTETRIC HAEMORRHAGE IN LATE TERMINATION OF PREGNANCY
|
| Sekhar M., Narat S., LeDieu R., Luqmani A., Hollamby S., Alobaidi M., Hughes G. |
| |
|
MALDI-TOF MS ANALYSIS DEMONSTRATES NUMEROUS HEPARIN SENSITIVE PEAKS IN THE SERUM PEPTIDOME OF NORMAL HEALTHY INDIVIDUALS
|
| Goodwin C.A., Scully M.F., Kakkar A.K. |
| |
|
MALDI-TOF MS ANALYSIS DEMONSTRATES NUMEROUS PEAKS ARE DIFFERENT IN THE SERUM PEPTIDOME IN COMPARISON TO THE PLASMA PEPTIDOME
|
| Goodwin C.A., Scully M.F., Kakkar A.K. |
| |
|
MALE GENDER INCREASES RISK OF VTE RECURRENCE AFTER SPONTANEOUS AND RISK-ASSOCIATED FIRST VENOUS THROMBOEMBOLISM
|
| Linnemann B., Schindewolf M., Zgouras D., Erbe M., Jarosch-Preusche M., Lindhoff-Last E. |
| |
|
MANAGEMENT OF AT ACTIVITY LEVELS WITH ANTITHROMBIN ALFA IN HEREDITARY AT DEFICIENT PATIENTS DURING SURGERY
|
| Tait R.C., Frieling J.T.M., Drenth H.J., Bonfiglio J. |
| |
|
MANAGEMENT OF ORTHOPAEDIC SURGICAL PROCEDURES IN PATIENTS WITH HAEMOPHILIA A RETROSPECTIVE COMPARISON BETWEEN INTERMITTENT BOLUS FACTOR INFUSIONS VS. CONTINUOUS FACTOR INFUSION FROM A TERTIARY CENTRE IN INDIA
|
| Viswabandya A., Nithyanath M., Cherian V.M., Lee V., Mathews V., Baidya S., Nair S.C., George B., Chandy M., Srivastava A. |
| |
|
MANAGEMENT OF SERIOUS HEMATOMAS IN PATIENTS ON CHRONIC ORAL ANTICOAGULATION: BALANCE BETWEEN IMMEDIATE AND LONG-TERM RISKS
|
| Casais P., Meschengieser S.S., Sánchez-Luceros A., Hendler M.F., Caruso V., Lazzari M.A. |
| |
|
MANAGEMENT OF SEVERE PULMONARY EMBOLISM IN A PATIENT WITH HOMOZYGOUS PROTEIN C DEFICIENCY
|
| Struve S., Beneke H., Schuetze B., Griesshammer M. |
| |
|
MANAGEMENT OF VENOUS AND ARTERIAL THROMBOSIS IN CHILDREN
|
| Price V., Chan A.K.C. |
| |
|
MANAGING PERI-DELIVERY ANTICOAGULATION IN WOMEN ON THERAPEUTIC DOSE LOW-MOLECULAR WEIGHT HEPARIN: A ROLE FOR UNFRACTIONATED HEPARIN
|
| Austin S.K., Lambert J., Peebles D., Cohen H. |
| |
|
MANAGING SUSPECTED VENOUS THROMBOEMBOLISM IN A MIXED PRIMARY AND SECONDARY CARE SETTING USING STANDARD CLINICAL ASSESSMENT AND D-DIMER IN A NON-INVASIVE DIAGNOSTIC STRATEGY
|
| de Bastos M., de Bastos M.R.D., Pessoa P.C.H., Bogutchi T., Carneiro-Proietti A.B.F., Rezende S.M. |
| |
|
MAPPING QUANTITIVE TRAIT NUCLEOTIDES (QTN) IN THE F12 GENE REVEALED THAT THE C46T IS THE MAIN FUNCTIONAL VARIANT
|
| Mordillo C., Buil A., Almasy L., Souto J., Blangero J., Fontcuberta J., Soria J. |
| |
|
MARKED EMPERIPOLESIS AND INCREASED P-SELECTIN EXPRESSION ON MEGAKARYOCYTES IN A NOVEL CASE OF GRAY PLATELET SYNDROME
|
| De Candia E., Larocca L.M., Pecci A., Balduini C.L. |
| |
|
MARKEDLY IMPAIRED BUT SIGNIFICANT THROMBIN-CATALYZED FIBRIN POLYMERIZATION OBSERVED AT VARIANT FIBRINOGENS AT GAMMA364ASP RESIDUE IS ARISEN FROM B-KNOB AND B-HOLE BONDING
|
| Okumura N., Terasawa F., Fujihara N., Hirota-Kawadobora M. |
| |
|
MARKERS OF ENDOTHELIAL CELL ACTIVITY BEFORE AND AFTER BOSENTAN THERAPY IN PATIENTS WITH SEVERE PULMONARY HYPERTENSION DUE TO CONNECTIVE TISSUE DISEASE
|
| Cella G., Cozzi F., Marotta H., Saggiorato G., Sartori M.T., Tona F., Iqbal O., Fareed J. |
| |
|
MARKERS OF FIBRINOLYSIS ARE INDEPENDENTLY RELATED TO FATTY LIVER AND HYPERTRIGLYCERIDEMIA IN FAMILIAL COMBINED HYPERLIPIDEMIA; EVIDENCE FOR INVOLVEMENT OF APOLIPOPROTEIN E
|
| Brouwers M.C.G.J., Govers-Riemslag J.W.P., Schalkwijk C.G., van Greevenbroek M.M.J., van der Kallen C.J.H., Bekers O., van Dieijen-Visser M.P., ten Oever J., Bilderbeek-Beckers M.A.L., de Bruin T.W.A., ten Cate H., Stehouwer C.D.A. |
| |
|
MASSIVE BLEEDINGS IN GIRLS DURING AND AFTER TERATOMAS EXCISION
|
| Svirin P.V., Glibina T.M., Vdovin V.V., Shiller E.E., Larina L.E., Sirotkina N.N., Ageenkova E.V. |
| |
|
MASSIVE VENOUS THROMBOEMBOLISM IN A PEDIATRIC PATIENT: A CASE REPORT
|
| Mariz M., Morais S., Corbillón L., Pereira M., Matos R., Guedes M., Medina M., Campos M. |
| |
|
MATERNAL PLATELETS AND THE THROMBIN RECEPTOR, PAR4, DISRUPT PLACENTAL MORPHOGENESIS AND CAUSE FETAL LOSS IN FACTOR V LEIDEN MICE
|
| Sood R., Zogg M., Westrick R.J., Guo Y., Kerschen E.J., Weiler H. |
| |
|
MATRIX METALLOPROTEIN-9 IS ELEVATED IN BLOOD FROM PATIENTS WITH PULMONARY EMBOLISM AND RIGHT VENTRICULAR HYPOKINESIS ON ECHOCARDIOGRAPHY
|
| Hernandez J., Kline J.A. |
| |
|
MATRIX METALLOPROTEINASE 9 (MMP-9), THROMBIN-ANTITHROMBIN COMPLEXES (TAT) AND THE FACTOR XIII VAL34LEU POLYMORPHISM IN PATIENTS WITH SPONTANEOUS ACUTE INTRACRANIAL HEMORRHAGE
|
| Tirado I., Mateo J., Marti-Fabregas J., Cocho D., Borrell M., Companys E., Ortin R., Marti-Vilalta J., Fontcuberta J. |
| |
|
MATRIX METALLOPROTEINASE-3, TISSUE INHIBITOR OF METALLOPROTEINASES-1 AND WARFARIN TREATMENT
|
| Kozak M., Bozic M., Stegnar M. |
| |
|
MAXIMAL AND LATE ADP INDUCED PLATELET AGGREGATION IN CORONARY ARTERY DISEASE PATIENTS ON DUAL ANTIPLATELET THERAPY
|
| Panicca R., Antonucci E., Gori A., Marcucci R., Romano E., Rossi L., Claudia S., Prisco D., Abbate R., Gensini G. |
| |
|
MEAN PLATELET VOLUME (MPV) IS AN INDEPENDENT RISK FACTOR FOR VENOUS THROMBOEMBOLISM (VTE). THE TROMS STUDY
|
| Braekkan S., Mathiesen E.B., Njolstad I., Wilsgaard T., Stormer J., Hansen J. |
| |
|
MEASUREMENT OF ENDOTHELIAL MICROPARTICLES IN BLOOD IS IMPAIRED IF CHYLOMICRONS ARE PRESENT AFTER A FATTY MEAL
|
| Fox S.C., May J.A., Heptinstall S. |
| |
|
MEASUREMENT OF THROMBIN GENERATION AND APC-RESISTANCE IN MOUSE PLASMA
|
| Tchaikovski S.N., van Vlijmen B.J.M., Rosing J., Tans G. |
| |
|
MEASUREMENT OF THROMBIN GENERATION IN PATIENTS AT RISK FOR ATHEROTHROMBOSIS
|
| Kaufmann V., Mager J., Laemmle B., Redondo M., Binder B.R. |
| |
|
MEASUREMENT OF THROMBUS STABILITY PREDICTS CORONARY EVENTS POST-PERCUTANEOUS CORONARY INTERVENTION (PCI)
|
| Sim D.S., Phillips D.R., Finn A.V., Gold H.K., Andre P. |
| |
|
MEASUREMENTS OF FIBRINOGEN AND CRP CONCENTRATIONS IN EDTA AND CITRATE PLASMA
|
| Skeppholm M., Wallén H., Blombäck M., Kallner A. |
| |
|
MEASURES OF THROMBIN GENERATION DURING CARDIOPULMONARY BYPASS (CPB) IN
|
| Ignjatovic V., Chandramouli A., Monagle P., Than J., Cochrane A., Furmedge J., Bennett M., Horton S. |
| |
|
MEASURING MICROPARTICLES: PITFALLS AND MODIFICATIONS
|
| Shah M.D., Bergeron A., Dong J., Lopez J.A. |
| |
|
MECHANICS OF PROPLATELET ELABORATION
|
| Italiano Jr. J.E., Patel S., Hartwig J.H. |
| |
|
MECHANISM FOR THE INHIBITORY EFFECT OF TETRAMETHYLPYRAZINE ON THE EXPRESSION OF TISSUE FACTOR INDUCED BY TUMOR NECROSIS FACTOR IN ECV304 CELLS
|
| Zhao Y., Xiong S.L. |
| |
|
MECHANISM OF BLOOD COAGULATION TRIGGERING: A MATHEMATICAL MODEL
|
| Tyurin K.V., Khanin M.A., Platonov A. |
| |
|
MECHANISM OF PARADOXICAL PLATELET ACTIVATION INDUCED BY GPIIB/IIIA ANTAGONISTS
|
| Bassler N., Loeffler C., Mangin P., Yuan Y., Schwarz M., Hagemeyer C.E., Eisenhardt S.U., Ahrens I., Bode C., Jackson S.P., Peter K. |
| |
|
MECHANISMS ASSOCIATED WITH FAILURE OF THROMBOLYTIC THERAPY TO RECANALIZE THE INFARCT ARTERY IN ACUTE MYOCARDIAL INFARCTION
|
| Huisse M.G., Feldman L., Guillin M.C., Steg P.G. |
| |
|
MECHANISMS COUPLING PROTEIN FOLDING AND TRANSPORT AT THE ER-GOLGI INTERFACE: ROLE IN F5F8D AND OTHER DISEASES
|
| Anelli T., Spreafico M., Bergamelli L., Ceppi S., Masciarelli S., Valetti C., Peyvandi F., Sitia R. |
| |
|
MECHANISMS OF FACTOR XIA INHIBITION BY TWO KUNITZ TYPE INHIBITORS, PROTEASE NEXIN 2 KPI DOMAIN AND BASIC PANCREATIC TRYPSIN INHIBITOR (BPTI)
|
| Navaneetham D., Sinha D., Walsh P.N. |
| |
|
MECHANISMS OF INACTIVATION OF COAGULATION FACTOR VIIIA BY ACTIVATED PROTEIN C WITH PROTEIN S
|
| Gale A.J., Rozenshteyn D. |
| |
|
MECHANISMS OF INDUCTION OF ENDOTHELIAL CELL E-SELECTIN EXPRESSION BY SMOOTH MUSCLE CELLS AND ITS INHIBITION BY SHEAR STRESS
|
| Chiu J., Chen L., Lee C., Lee P., Usami S., Chien S. |
| |
|
MECHANISMS OF INHIBITION OF THROMBIN-INDUCED PLATELET ACTIVATION BY FIBRINOGEN GAMMA'(408-427) PEPTIDE
|
| De Cristofaro R., Vastola M., Di Stasio E. |
| |
|
MECHANISMS OF THROMBUS FORMATION DIFFER BETWEEN ATHEROSCLEROTIC AND NORMAL ARTERIES IN HYPERCHOLESTEROLEMIC RABBITS
|
| Yamashita A., Matsuda S., Takahashi M., Sumi T., Nishihira K., Imamura T., Kitamura K., Asada Y. |
| |
|
MEGAKARYOCYTE-RESTRICTED MHY9 INACTIVATION LEADS TO MEGAKARYOCYTE AND PLATELET ULTRASTRUCTURAL ABNORMALITIES
|
| Eckly A., Strassel C., Lanza F., Cazenave J., Gachet C., Leon C. |
| |
|
MEGAKARYOCYTE-RESTRICTED MYH9 INACTIVATION DRAMATICALLY AFFECTS HAEMOSTASIS WHILE PRESERVING PLATELET AGGREGATION AND SECRETION RESPONSES
|
| Leon C., Eckly A., Hechler B., Aleil B., Freund M., Nonne C., Weber J., Tiedt R., Gratacap M., Séverin S., Cazenave J., Lanza F., Skoda R., Gachet C. |
| |
|
MENORRHAGIA ASSOCIATED WITH LABORATORY ABNORMALITIES OF HEMOSTASIS: EPIDEMIOLOGICAL, DIAGNOSTIC AND THERAPEUTIC ASPECTS
|
| Kouides P.A., Kadir R.A. |
| |
|
MESOTHELIAL RAGE ACTIVATION BY AGES ENHANCES VEGF RELEASE AND POTENTIATES CAPILLARY TUBE FORMATION
|
| Grossin N., Wautier M., Taamma R., Wautier J., Boulanger E. |
| |
|
METABOLIC SYNDROME AND HYPERHOMOCYSTEINEMIA IN PATIENTS WITH DEEP VEIN THROMBOSIS: A CASE-CONTROL STUDY
|
| Dentali F., Ageno W., Romualdi E., Prandoni P., Ghirarduzzi A., Pesavento R., Venco A. |
| |
|
METABOLIC SYNDROME IN ISCHEMIC STROKE PATIENTS' CHILD
|
| Iqbal M., Ranakusuma T., Haris S., Soebardi S., Prihartono J. |
| |
|
METABOLIC SYNDROME, PAI-1 AND COLLATERAL VESSEL FORMATION IN PATIENTS WITH DOCUMENTED OCCLUDED CORONARY ARTERIES
|
| Susen S., Mouquet F., Cuilleret F., Ennezat P., Sautiere K., Dallongeville J., Jude B., Van Belle E. |
| |
|
MICE TRANSGENIC FOR THROMBOMODULIN EXHIBIT PROTECTION FROM VENOUS THROMBOSIS
|
| Nandurkar H., Zhang M., Dezfouli S., Crikis S., Dwyer K., Murray-Segal L., Cowan P., d'Apice A. |
| |
|
MICROPARTICLES DURING THE COURSE OF PAINFUL CRISES IN SICKLE CELL DISEASE
|
| van Beers E.J., Schaap M.C.L., Berckmans R.J., Nieuwland R., Sturk A., Biemond B.J. |
| |
|
MICROPARTICLES FROM APOPTOTIC MONOCYTES (M-MPS) INDUCE TRANSIENT PLATELET RECRUITMENT AND TISSUE FACTOR (TF) EXPRESSION BY CULTURED HUMAN VASCULAR ENDOTHELIAL CELLS VIA A REDOX-SENSITIVE MECHANISM
|
| Essayagh S., Xuereb J., Terrisse A., Cirioni-Tellier L., Pipy B., Sie P. |
| |
|
MICROPARTICLES IN THROMBIN GENERATION - A SIGNIFICANT PARAMETER INFLUENCING PEAK THROMBIN LEVELS
|
| Kaufmann V., Mager J., Eichinger S., Binder B.R. |
| |
|
MICROPARTICLES' INDUCE PRO-COAGULANT AND APOPTOTIC EFFECTS ON ENDOTHELIAL CELLS
|
| Aharon A., Tamari T., Brenner B. |
| |
|
MICROPARTICLES PROCOAGULANT ACTIVITY IN CITRATED PLASMA
|
| Vissac A.M., Peyrafitte M., Amiral J.J. |
| |
|
MILD CONGENITAL ADAMTS13 DEFICIENCY DUE TO ONE MISSENSE MUTATION TOGETHER WITH FOUR AMINO ACID POLYMORPHISMS IN A PATIENT WITH FAMILIAL RECURRENT ISCHEMIC STROKE
|
| Plaimauer B., Böhm-Weigert M., Antoine G., Scharrer I., Scheiflinger F. |
| |
|
MILD HAEMOPHILIA A (P. A1824T) ASSOCIATED WITH HEREDITARY COAGULATION FACTOR XII DEFICIENCY AND HETEROZYGOUS PROTHROMBIN 20210G/A MUTATION
|
| Perez R., Nunez R., Garcia-Lozano R., Fernandez O. |
| |
|
MINOR LEG INJURIES INCREASE VENOUS THROMBOTIC RISK FIVE FOLD
|
| van Stralen K.J., Rosendaal F.R., Doggen C.J.M. |
| |
|
MISSENSE MUTATIONS IN THE COILED-COIL REGION OF FIBRINOGEN AALPHA CHAIN CAUSE FIBRINOGEN DEFICIENCY BY IMPAIRING DIMERIZATION OF TRIMERIC INTERMEDIATES
|
| Platè M., Asselta R., Spena S., Peyvandi F., Duga S., Tenchini M. |
| |
|
MISUSE OF THE D-DIMER TEST IN HOSPITALISED PATIENTS
|
| Girard P., Lenoir S., Stern J., Strauss C., Caliandro R., Le Guillou J., Touitou C. |
| |
|
MODERATE ALCOHOL CONSUMPTION DECREASES THE RISK OF VENOUS THROMBOSIS
|
| Pomp E.R., Rosendaal F.R., Doggen C.J.M. |
| |
|
MODERATE HYPERHOMOCYSTEINEMIA IS ASSOCIATED WITH REDUCED PLASMA FIBRINOLYTIC CAPACITY AND INCREASED TAFI LEVELS
|
| Colucci M., Semeraro F., Cattaneo M., Martinelli I., Semeraro N. |
| |
|
MODIFICATION BY PAI-1 OF SLOW EXOCYTOTIC DYNAMICS OF TISSUE PLASMINOGEN ACTIVATOR (TPA) AND ITS ACTIVITY ON VASCULAR ENDOTHELIAL CELLS (VECS)
|
| Suzuki Y., Ihara H., Mogami H., Urano T. |
| |
|
MODIFIED CRP ENHANCES PLATELET ADHESION AND THROMBUS GROWTH ON COLLAGEN
|
| Molins B., Peña E., Vilahur G., Mendieta C., Badimon L. |
| |
|
MODIFIED PLATELETS FUNCTION ANALYSIS TO RATIONALIZE CHOLESTEROL ELIMINATION PROCEDURE
|
| Blazek M., Blaha M., Maly J., Pecka M., Blaha V., Masin V. |
| |
|
MODULATION OF DENDRITIC CELL FUNCTION BY TISSUE FACTOR AND COAGUALTION PROTEASES
|
| Shrivastava S., Dorling A. |
| |
|
MODULATION OF HEPARIN-PF4 ANTIBODY-MEDIATED PLATELET ACTIVATION BY A NOVEL GPIIB/IIIA RECEPTOR ANTAGONIST: IMPLICATIONS IN THE MANAGEMENT OF HIT
|
| Mousa S.A., Ahmad S. |
| |
|
MODULATION OF NITRIC OXIDE PRODUCTION BY CULTURED ENDOTHELIAL CELLS
|
| Osadchenko I.A., Kovalenko T.N., Skibo G.G. |
| |
|
MODULATION OF PLATELET FUNCTION BY THE ENDOCANNABINOID 2-ARACHIDONOYLGLYCEROL
|
| Baldassarri S., Bertoni A., Lova P., Sarasso C., Zanfa M., Catani M., Avigliano L., Maccarrone M., Torti M., Sinigaglia F. |
| |
|
MODULATION OF PLATELET REACTIVITY BY ERYTHROCYTES IN CORONARY ARTERY DISEASE PATIENTS TAKING ASPIRIN
|
| Shirokova T.E., Buriachkovskaia L.I., Uchitel I.A., Sumarokov A.B., Popov E.G. |
| |
|
MODULATION OF STAPHYLOKINASE-DEPENDENT PLASMINOGEN ACTIVATION BY OMEGA-AMINE ACIDS
|
| Levashov M.Y., Aisina R.B., Gershkovich K.B., Varfolomeyev S.D., Mukhametova L.I. |
| |
|
MODULATION OF THE RISK OF CORONARY ARTERY DISEASE BY THE INTERACTION BETWEEN FACTOR XIII SUBUNIT A VAL34LEU POLYMORPHISM AND FIBRINOGEN CONCENTRATION IN THE HUNGARIAN POPULATION
|
| Katona É., Bereczky Z., Balogh E., Pocsai Z., Czuriga I., Széles G., Ádány R., Édes I., Muszbek L. |
| |
|
MODULATION OF VON WILLEBRAND A1 DOMAIN FUNCTION BY THE HOMOLOGOUS DOMAINS A2 AND A3
|
| Podda G.M., Roberts J.R., Ruggeri Z.M. |
| |
|
MOLECULAR AND CELLULAR DYNAMICS OF MOESIN IN VASCULAR CELLS VIA MECHANO-TRANSDUCTION
|
| Britto M., Fitzpatrick P., Meade G., Cahill P.A., Cummins P.M., Murphy R.P. |
| |
|
MOLECULAR AND FUNCTIONAL CHARACTERIZATION OF FVIII MUTATIONS IN A FEMALE WITH SEVERE HEMOPHILIA A
|
| dos Santos A., Montalvão S.A.L., Furlan Freguia C., de Paula E.V., Annichino-Bizzacchi J.M., Camire R.M., Ozelo M.C. |
| |
|
MOLECULAR AND FUNCTIONAL DIVERSITY OF SNAKE VENOM VEGFS
|
| Matsunaga Y., Obayashi S., Yamazaki Y., Morita T. |
| |
|
MOLECULAR BASIS OF ANTITHROMBIN DEFICIENCY IN FOUR JAPANESE PATIENTS WITH PREGNANCY-ASSOCIATED THROMBOSIS: ANTITHROMBIN GENE ABNORMALITIES INCLUDING TWO NOVEL MUTATIONS
|
| Okumura K., Fujimori Y., Kashiwagi T., Sanda N., Yamada T., Takagi A., Murate T., Iwasaki T., Katsumi A., Yamamoto K., Matsushita T., Naoe T., Saito H., Kojima T. |
| |
|
MOLECULAR CHARACTERIZATION OF A 4.4MBP DELETION OF THE HUMAN X CHROMOSOME IN A PATIENT WITH HAEMOPHILIA B
|
| Hewitt J., Chou E., Brown L.A., Smith V.C., Huntsman D.G., Brown C., Yong S., Wadsworth L.D., Wu J., MacGillivray R.T.A. |
| |
|
MOLECULAR IMAGING OF THROMBI USING A BIMODAL A2-ANTIPLASMIN-BASED CONTRAST AGENT
|
| Miserus R.J., Dirksen A., Douma K., van Zandvoort M.A.M.J., Daemen M.J.A.P., Heeneman S., Kooi E., Hackeng T.M. |
| |
|
MOLECULAR MARKERS OF BLOOD HYPERCOAGULABILITY IN HETEROZYGOUS CARRIERS OF FACTOR V LEIDEN MUTATION
|
| Miljic P.S., Elezovic I., Djordjevic V., Colovic M. |
| |
|
MOLECULAR MECHANISM OF INTERACTION BETWEEN ACTIVATED FACTOR XIII AND ITS ACYL DONOR PEPTIDE SUBSTRATE
|
| Muszbek L., Pénzes K., Komáromi I., Kárpáti L., Kövér K. |
| |
|
MOLECULAR MECHANISMS ACCOUNTING FOR FIBRINOGEN DEFICIENCY: FROM LARGE DELETIONS TO INTRACELLULAR RETENTION OF MISFOLDED PROTEINS
|
| Vu D., Neerman-Arbez M. |
| |
|
MOLECULAR MECHANISMS IN TWO CHINESE PATIENTS WITH INHERITED AFIBRINOGENEMIA
|
| Fang Y., Wang X., Chen F., Wang H., Wang Z. |
| |
|
MOLECULAR MODEL OF THE PREKALLEKREIN STRUCTURE
|
| Emsley J., Hooley E., Mcewan P. |
| |
|
MONITORING AND DOSAGE MODULATION OF ENOXAPARIN DURING PREGNANCY
|
| Lambert C., Dessomme B., Deneys V., Hermans C. |
| |
|
MONITORING AND THERAPY OF SEVERE ANTITHROMBIN DEFICIENCY IN PREGNANT WOMEN
|
| Siegemund A., Scholz U., Thamm-Mücke B., Siegemund T. |
| |
|
MONITORING HAEMOSTATIC RESPONSE USING DYNAMIC FIBRIN GENERATION METHODS
|
| Sørensen B., Ingerslev J. |
| |
|
MONITORING HEPARIN LEVELS IN CHILDREN DURING CARDIAC CATHETERIZATION: COMPARISON OF ACTIVATED CLOTTING TIME, ACTIVATED PARTIAL PROTHROMBIN TIME, AND ANTI-XA ACTIVITY
|
| Hanslik A., Karapetian H., Prutsch N., Kitzmueller E., Greber-Platzer S., Haumer M., Thom K., Male C. |
| |
|
MONITORING NOVOSEVEN THERAPY WITH DIFFERENT METHODS
|
| Siegemund T., Siegemund R., Petros S., Engelmann L. |
| |
|
MONITORING OF ANTIPLATELET THERAPY BEFORE AND AFTER SURGICAL PROCEDURES IN PATIENTS WITH CORONARY STENTS
|
| Spannagl M., Kunz S., Calatzis A., Klauss V. |
| |
|
MONITORING OF LOW MOLECULAR WEIGHT HEPARIN NADROPARIN DURING HEMODIALYSIS
|
| Berruyer M., El Rouby S., Yasar Z., Durbin S., Ffrench P., Galland P., Leitienne P. |
| |
|
MONITORING OF ORAL ANTICOAGULANT THERAPY IN CHILDREN: COMPARISON OF COAGUCHEK XS WITH VENOUS INR
|
| Greenway A., Ignjatovic V., Summerhayes R., Newall F., Monagle P.T. |
| |
|
MONITORING OF PLATELET FUNCTION AFTER CLOPIDOGREL TREATMENT
|
| Lee Y., Kim H., Kang H., Cho H. |
| |
|
MONITORING OF RECOMBINANT FVIIA BY THROMBIN GENERATION TEST
|
| Dargaud Y., Lienhart A., Negrier C. |
| |
|
MONITORING THROMBIN GENERATION IN WHOLE BLOOD BY ELECTROCHEMISTRY - A NEW APPROACH FOR SCREENING THROMBOPHILIC AND HEMOPHILIC RISKS
|
| Thürlemann C., Frenkel E.J., Dinger R., Haeberli A., Alberio L. |
| |
|
MONITORING UNFRACTIONATED HEPARIN IN A PATIENT WITH RENAL AND HEPATIC INSUFFICIENCY YIELDS DISCORDANT RESULTS COMPARING ANTI-XA ASSAY AND PARTIAL THROMBOPLASTIN TIME. A CASE REPORT
|
| Padmore R.F., Calvert M. |
| |
|
MONOCLONAL ANTIBODIES THAT MIMIC ANTIBODIES FOUND IN PATIENTS WITH DRUG (QUININE(QN))-INDUCED IMMUNE THROMBOCYTOPENIA (DITP): IMPLICATIONS FOR THE PATHOGENESIS OF DITP
|
| Bougie D.W., Birenbaum J., Ahl S., Aster R.H. |
| |
|
MONOCYTE IL-10 PRODUCED IN RESPONSE TO LPS MODULATES THROMBIN GENERATION BY INHIBITING TISSUE FACTOR EXPRESSION AND RELEASE OF ACTIVE TISSUE FACTOR-BOUND MICROPARTICLES
|
| Poitevin S., Cochery-Nouvellon E., Nguyen P. |
| |
|
MONOCYTE PARAMETERS TO DISCRIMINATE ESSENTIAL FROM REACTIVE THROMBOCYTOSIS
|
| Jean A., Gromellon N., Piquenot J., Basuyau J., Bastard C., Lenormand B., Vasse M. |
| |
|
MONOCYTE PLATELET COMPLEXES: A POTENTIAL FLOW CYTOMETRIC ASSAY FOR SCREENING PRE-THROMBOTIC EVENTS IN HIV POSITIVE PATIENTS
|
| Lawrie D., Glencross D.K., Jacobson B. |
| |
|
MONOCYTE RESPONSE TO ACTIVATED PLATELETS: A TRANSCRIPTIONAL STUDY
|
| Farrugia R., Gusnanto A., Ellis P., Langford C.F., Goodall A.H., Watkins N.A., Ouwehand W.H. |
| |
|
MONOCYTES DOWN-REGULATE INITIAL PHASE OF COLLAGEN-INDUCED PLATELET ACTIVATION
|
| Ollivier V., Arnaud B., El Benna J., Jandrot-Perrus M., Ajzenberg N. |
| |
|
MORE SEVERE HYPERCOAGULABLE STATE IN PROTHROMBIN G20210A CARRIERS THAN IN NON-CARRIERS WITH COMPARABLE PROTHROMBIN LEVELS
|
| Castoldi E., Simioni P., Tormene D., Thomassen M.C.L.G., Spiezia L., Gavasso S., Rosing J. |
| |
|
MORE THAN ONE EPISODES IN CHILDHOOD ITP WITH A MEDIASTINUM OF MONTHS OR YEARS. A 30 YEARS RETROSPECTIVE ANALYSIS
|
| Vranou M., Pergantou H., Platokouki H., Aronis S. |
| |
|
MORPHOLOGIC EVIDENCE OF INTRAVASCULAR PLATELET ACTIVATION WITH GENERATION OF PLATELET MICROPARTICLES & EXOSOMES IN MURINE HEPATIC SCHISTOSOMIASIS AND ITS MODULATION BY PENTOXIFYLLINE TREATMENT
|
| Lotfi A. |
| |
|
MORTALITY BENEFIT OF FONDAPARINUX VERSUS ENOXAPARIN IN DIABETIC PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES (NSTE-ACS): A SUBANALYSIS OF OASIS-5
|
| Peters R., Mehta S.R. |
| |
|
MRNA ANALYSIS IN A SEVERE HAEMOPHILIA A PATIENT: DETECTION OF AN EXON 6 SKIPPING
|
| Vinciguerra C., Martel F., Pellecchia D., Fretigny M., Negrier C. |
| |
|
MTHFR C677T HOMOZYGOSITY AND RECURRENT FETAL LOSS
|
| Altomare I., Aledort L.M. |
| |
|
MULTICENTER, PROSPECTIVE VALIDATION OF A DECISION RULE TO REDUCE EXCESS DIAGNOSTIC TESTING FOR PULMONARY EMBOLISM IN THE EMERGENCY DEPARTMENT
|
| Kline J.A., Kline J.A., Courtney D.M., Than M.P., Kabrhel C., Moore C.L., Smithline H.A., Plewa M.C., McCubbin T.R., Richman P.B., O'Neil B.J., Beam D.M., Nordenholz K.E., Johnson C.L. |
| |
|
MULTI-DETECTOR SPIRAL COMPUTED TOMOGRAPHY ALONE VERSUS COMBINED WITH LOWER LIMB COMPRESSION ULTRASONOGRAPHY IN OUTPATIENTS SUSPECTED OF PULMONARY EMBOLISM: A RANDOMISED NON-INFERIORITY TRIAL
|
| Righini M., Le Gal G., Aujesky D., Verschuren F., Roy P., Sanchez O., Meyer G., Bounameaux H., Perrier A. |
| |
|
MULTIFACTORIAL ANALYSIS USING FOUR PHOSPHOLIPIDS TO THOROUGHLY INVESTIGATE CONTROL OF THROMBOPLASTIN PROPERTIES AND SENSITIVITIES
|
| Cawthern K., Bottenus R., Rawal D., Triscott M. |
| |
|
MULTIMODALITY INTRAOPERATIVE IMAGING OF THROMBI IN THICK-WALLED BLOOD VESSELS OF LARGE ANIMALS USING NEAR INFRARED FLUORESCENCE
|
| Flaumenhaft R., Tanaka E., Graham G.J., Lawrence R.G., Henary M., Patonay G., Frangioni J.V. |
| |
|
MULTINATIONAL DEVELOPMENT OF A QUESTIONNAIRE ASSESSING PATIENT SATISFACTION WITH ANTI-COAGULANT TREATMENT
|
| Prins M.H., Arnould B., Leguet P., Caire P., Raskob G., Marrel A. |
| |
|
MULTIPLE REDOX SYSTEMS OPERATE IN EXTRACELLULAR REGULATION OF INTEGRIN-MEDIATED PLATELET ADHESION
|
| Lahav J. |
| |
|
MULTIPLE SITES OF FXIIIA ARE INVOLVED IN THE BINDING INTERACTION TO THE ALPHA CHAIN OF FIBRINOGEN
|
| Adamson P.J., Smith K.A., Dissanayake M.P., Ariens R.A.S., Grant P.J., Philippou H. |
| |
|
MUNCHAUSEN SYNDROME X COAGULOPATHIES
|
| Villaça P.R., Bassitt R.P., Zeinad A.K., Chamone D.F., D'Amico E.A. |
| |
|
MURINE GPVI ANTIBODY DOES NOT INDUCE GPVI-DEPLETION BUT REDUCES IN VIVO THROMBOSIS WITH MINIMAL BLEEDING RISK IN RATS
|
| Lockyer S., Li H., Concepcion A., Gong X., Matsumoto Y., Takizawa H., Kambayashi J., Liu Y., Tandon N.N. |
| |
|
MUTATED POSITION OF NMHC-A PREDICTS THE NATURAL HISTORY OF MYH9-RELATED DISEASE
|
| Pecci A., Panza E., Pujol-Moix N., Di Bari F., Bozzi V., Klersy C., Gresele P., Lethagen S., Fabris F., Dufour C., Granata A., Doubek M., Pecoraro C., Koivisto P.A., Molinas F.C., Iolascon A., Alvisi P., Schwabe D., De Candia E., Rocca B., Russo U., Ramenghi U., Noris P., Seri M., Balduini C.L., Savoia A. |
| |
|
MUTATION SCREENING ANALYSIS OF TGFBR1 GENE IN PATIENTS WITH MARFAN SYNDROME
|
| Lucarini L., Evangelisti L., Attanasio M., Fatini C., Sticchi E., Romano E., Cellai A., Pepe G., Abbate R., Gensini G. |
| |
|
MUTATIONS AT THE LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN (LRP) BINDING SITE OF THE FVIII A2 DOMAIN DID NOT REDUCE LRP BINDING OR INCREASE HALF-LIFE OF NON-ACTIVATED FVIII
|
| Tang L., Murphy J.E., Barnett T., Mei B., Pamarthi M., Strauss J., Tjandra J., Chen Y., Dryga O., Medvedeff G., Nixon J., Chamberlain D., Newgren J., Fournel M. |
| |
|
MUTATIONS IN THE MCFD2 GENE ARE PREDOMINANT AMONG PATIENTS WITH HEREDITARY COMBINED FACTOR V AND FACTOR VIII DEFICIENCY (F5F8D) IN INDIA
|
| Giridhara Rao J., Spreafico M., Viswabandya A., Nair S.C., Chandy M., Srivastava A., Peyvandi F. |
| |
|
MUTATIONS THAT RENDER VON WILLEBRAND FACTOR (VWF) RESISTANT TO ADAMTS13 CLEAVAGE
|
| Desch K., Ginsburg D. |
| |
|
MYOCARDIAL GENE TRANSFER OF VASCULAR ENDOTHELIAL GROWTH FACTOR FOR THERAPEUTIC ANGIOGENESIS IN CORONARY ARTERY DISEASE
|
| Ojalvo A.G., Gonzalez M.J., Seralena A., Gonzalez N., Villar A., Garzon E., Chaos N., Reina C., Gonzalez R., Chil R., Suarez L.R., Mendez T., Senra G., Milan R., Batista J.F., Peña Y., Coca M., Fleites G., Vazquez R., Betancourt B.Y., Guevara L., Nafeh M., Garcia E., Vispo N.S. |
| |
|
MYOCARDIAL INFARCTION AFTER OVARIAN STIMULATION FOR INFERTILITY MANAGEMENT
|
| Girolami A., Tezza F., Scandellari R., Scapin M., Girolami B. |
| |
|
MYONECROSIS IS PREDICTED BY HIGH REACTIVITY TO MULTIPLE PLATELET AGONISTS: A TRANSLATIONAL STUDY OF PATIENTS UNDERGOING STENTING TREATED WITH BIVALIRUDIN AND HIGH DOSE CLOPIDOGREL
|
| Bliden K.P., DiChiara J., Tantry U.S., Singla A., Gurbel P.A. |
| |
